countries that adopted westernized diet and lifestyle, have a higher PCa incidence, [3] [4] [5] [6] suggesting an important role for diet in PCa etiology and/or progression.
It was highlighted that populations with a high omega-3 (ω3) dietary content have lower PCa incidence. 7 Unfortunately, western diet has changed significantly in this century and led to a dramatic decrease of ω3 consumption, resulting in a reduced dietary ω3:ω6 ratio. 8, 9 ω3 and ω6 are both essential fatty acids (FA) provided by diet and their ratio in prostate tissue has been correlated to presence of PCa. 10, 11 Level of ω3 FA in prostate tissue has been inversely related to PCa progression risk during active surveillance. 12 Although some observational studies are inconclusive, the vast majority of observational, [13] [14] [15] [16] [17] [18] [19] [20] preclinical, [21] [22] [23] [24] [25] and clinical [26] [27] [28] [29] studies support beneficial effects of ω3 FA against PCa development and progression, likely via anti-inflammatory properties.
Prostate inflammation is among the significant risk factors associated with PCa. [30] [31] [32] In PCa, some inflammatory mediators are overexpressed in prostate tissue (eg, IL-1, IL-6, IL-8, TGF-β1, TNF-α) [33] [34] [35] [36] and systemically (eg, IL-6, IL-7, and IL-15). 37, 38 Circulating immune cells and their infiltration in prostate tumors have also been reported to be associated with PCa prognosis. 39, 40 Dietary fat is a major contributor to inflammation in prostate cells 41 and circulating ω3 FA levels have been inversely associated to prostatic inflammation. 42 Recently, it was shown that fish oil (high ω3:ω6 ratio) inhibits tumor growth and prostate tumor macrophages infiltration in androgen-sensitive MycCaP mouse model, 25 suggesting immune cells and inflammatory mediators to be favorably modulated following an ω3-rich diet.
PCa cells have an androgen-dependent growth. 43 Androgen deprivation is initially effective to treat PCa; however, PCa eventually progress to become castration-resistant, which is lethal for men.
Interestingly, androgens were reported as immunosuppressive and anti-inflammatory, exerting suppressive effects on both humoral and cellular immune responses. [44] [45] [46] [47] [48] Androgens withdrawal has been shown to impact immune cells infiltration directly in prostate tumors 49 and to modulate circulating inflammatory markers. 50 Since omega-3 has also been previously reported to delay castrated-resistant PCa in mouse, 51 we hypothesized that both androgen-sensitive and castrateresistant PCa could benefit from the anti-inflammatory and immunemodulatory effects of ω3-rich diet. Altogether, our study aimed at deciphering the targeted inflammatory mediators and immunomodulation underlying the ω3 FA anti-cancer effects on PCa tumors, including in a context of androgen deprivation, using the immunecompetent TRAMP-C2 murine model of PCa.
| MATERIALS AND METHODS

| Diets
Animal diets were based on the standard AIN93G diet formula and were purchased from Research Diets, Inc. (New Brunswick, NJ). A control balanced diet consisting in the AIN93G diet added with 10% of soybean oil (SO, ω3/ω6 ratio 0.15) was prepared. The ω6-enriched diet was prepared by adding 10% of safflower oil (SFO, ω3/ω6 ratio 0.002) while the ω3-enriched diet was prepared by adding 1% SFO and 9% menhaden fish oil (FO, ω3/ω6 ratio 3.3) to the AIN93G diet. All diets were isocaloric with FA representing 22% of daily Kcal intake, which is in the range of fat intake recommended by the Dietary Guidelines for Americans (Supplementary Table S1 ). 10 μg/mL poly(I:C) to induce an inflammatory response. Total protein was extracted and measured for cytokine expression using a multiplex immunoassay, as described in section 2.5.
| Mice experiments
This study protocol (2013111) has been approved by Institutional
Review Board of CHU de Québec-Université Laval. First, fourteen 6-8 weeks old C57BL/6 male mice were fed with the control balanced diet. After 2 weeks of feeding, half of mice were surgically castrated. After two additional weeks, seven castrated and seven eugonadal (non-castrated) mice were injected with 2 × 10 6 TRAMP-C2 cells subcutaneously (s.c.) on both flanks. After occurrence of the initial mass, tumor size was measured every other day and tumor volume was calculated using the formula: (shortest diameter) 2 × (longest diameter)/2. Mice were sacrificed when the tumor volume reached 2 cm 3 . Plasma, red blood cells (RBC) and tumors were collected from each mouse at sacrifice and stored at −80°C ( Figure 1B ). Similar protocols were followed with two groups of 10 C57BL/6 eugonadal mice ( Figure 2A ) and two groups of 15 C57BL/6 surgically castrated mice ( Figure 3A) , fed with either ω3-or ω6-enriched diets all along the experiment. 
| Multiplex immunoassay
The levels of cytokines in plasma, tumors, and TRAMP-C2 cells in 
| Flow cytometry analyses
| Statistical analysis
Difference of tumor growth between groups was performed by twoway ANOVA with repeated measures using Prism 7 (GraphPad Software, La Jolla, CA). Change in mice survival was measured by Log-rank test. Difference between both diets for cytokine, FA and immune cell profiles were assessed using the Mann-Whitney test.
Correlations between cytokines were performed using Spearman's rank correlation test. A P-value below 0.05 was considered significant.
3 | RESULTS
| ω3 FA reduce TRAMP-C2 cell proliferation in vitro independently of androgen levels
To first evaluate the effect of dietary ω3 FA, we exposed TRAMP-C2 cells in vitro to ω3-rich FO and ω6-rich SFO over time, in presence or absence of DHT. TRAMP-C2 proliferation was more importantly inhibited after exposure to ω3-rich FO than ω6-rich SFO in both, androgen-deprived and non-deprived conditions ( Figure 1A ). We also observed that cells were growing at a slower rate in DHT deprived media in vitro ( Figure 1A, bottom) confirming the androgen sensitivity of TRAMP-C2 cells as reported by others. 55 The impact of androgens on TRAMP-C2 growth was further tested in vivo. When TRAMP-C2 cells were implanted s.c., tumors grew faster in castrated mice than in eugonadal mice ( Figure 1C ), thus reducing survival time of castrated mice (P = 0.0028; Figure 1D ), a result . ω6 n = 14; ω3 n = 13: one mouse in ω6 group and two mice in ω3 group were excluded because they were sacrificed before end point due to ulceration. The log-rank test was used to determine statistical significance consistent with the increased aggressiveness of castration-resistant PCa over androgen-sensitive PCa.
3.2 | Dietary ω3 FA reduce TRAMP-C2 tumor growth in eugonadal and castrated mice
As ω3 FA reduced cell growth of TRAMP-C2 cells in presence and absence of androgens in vitro, we evaluated the role of ω3-enriched diet compared to ω6-enriched diet on TRAMP-C2 tumor growth in mice. There was no difference in body weight between mice on ω3 or ω6 diets, indicating that both diets were consumed equally (Supplementary Figure S1) . In eugonadal mice, TRAMP-C2 tumors of ω3-fed mice grew significantly slower than those of ω6-fed mice and hence, animals' survival was extended by 6-8 days (P = 0.0002; Figures 2B and 2C) . Similarly, in castrated mice, tumors of ω3-fed mice displayed reduced growth compared to ω6-fed tumors, which also resulted in a longer survival (P = 0.003; Figures 3B and 3C ). (Figures 4A and 4C) . Figures 4B and 4D ). This was translated into a high ω3:ω6 ratio in both tissues of ω3-fed mice and a low ω3:ω6 ratio in mice fed with a ω6-enriched diet. FA levels in RBC and tumors were not affected by androgens as FA levels were similar in eugonadal and castrated mice (Figure 4 ). and IL-13 levels were also higher; however, eotaxin-1 was not detected ( Figure 5B , lower panel).
|
| Eotaxin-1 secretion by tumor cells is induced by ω3 FA and is regulated by androgens
Among the cytokines that were modulated by dietary FA, eotaxin-1 (CCL11) has been associated with PCa risk. 57, 58 Eotaxin-1 is a major eosinophil-attractant chemokine. The role of eosinophils in cancer is being increasingly recognized and eosinophilia is associated with favorable anti-tumor immune responses. 59 To determine whether ω3 FA could directly modulate the expression of eotaxin-1, we tested the effect of purified ω3 FA DHA and EPA as well as purified ω6 FA AA on the secretion of eotaxin-1 by TRAMP-C2 cells in vitro. P value between ω3 and ω6 groups was calculated using Mann-Whitney test (*P ≤ 0.05). Each dot represents data from one mouse shown that a transient increase in eosinophils in blood and prostatic tissues was associated with prolonged survival in men with metastatic CRPC treated with Sipuleucel-T immunotherapy. 75 Such an association has been repeatedly observed in patients treated with antiimmune checkpoint immunotherapies. 76 Furthermore, lack or low expression of IL-33, another cytokine known to promote eosinophil infiltration and activity in tissues, was also associated with the progression of PCa. 77 In the same study, IL-33 complementation experiments showed a reduction of tumor growth by inducing eosinophil infiltration and phenotypic shifts in tumor-infiltrating lymphocytes. 77 In conclusion, we observed beneficial effects of ω3 FA on TRAMP-C2 tumor growth both in androgen non-deprived and androgen-deprived immune-competent syngeneic mice. The antitumor effects of ω3 FA were associated with a mixed Th1/Th2 cytokine response that may be important mechanisms underlying the ω3 FA effects on PCa. We also observed a direct growth inhibitory effect of ω3 FA when administered to TRAMP-C2 cells with or without DHT. A randomized controlled trial is actually ongoing to decipher the effects of a ω3-enriched diet on low-grade PCa progression in men (NCT01653925 We thank the staff of the animal facility of CRCHU de Québec-Université Laval at L'Hôpital-Enfant-Jésus for providing expert technical assistance. We also thank Line Berthiaume for the analysis of FA profiles. We finally thank Dr. Gabriel Lachance for the critical reading of this manuscript.
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